Global Inhalation CDMO Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Inhalation CDMO market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Inhalation CDMO is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Inhalation CDMO is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Inhalation CDMO is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Inhalation CDMO include Aptar Pharma, Bend Bioscience, Bespak, Catalent, CritiTech, Enteris Biopharma, Experic, HCmed and Hovione, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhalation CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation CDMO.

The Inhalation CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalation CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Inhalation CDMO Segment by Company

Aptar Pharma
Bend Bioscience
Bespak
Catalent
CritiTech
Enteris Biopharma
Experic
HCmed
Hovione
Iconovo
Kindeva
Lonza
Particle Sciences
Proveris
Recipharm
Renejix
Ritedose
Vectura
Sanner

Inhalation CDMO Segment by Type

Soft Mist Inhalers (SMIs)
Dry Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Others

Inhalation CDMO Segment by Application

Commercial
Academic Research
Others

Inhalation CDMO Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation CDMO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Inhalation CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Inhalation CDMO Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Inhalation CDMO Market Size by Region (2020-2031)
1.4.1 Global Inhalation CDMO Market Size by Region (2020-2025)
1.4.2 Global Inhalation CDMO Market Size by Region (2026-2031)
1.5 Key Regions Inhalation CDMO Market Size (2020-2031)
1.5.1 North America Inhalation CDMO Market Size Growth Rate (2020-2031)
1.5.2 Europe Inhalation CDMO Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Inhalation CDMO Market Size Growth Rate (2020-2031)
1.5.4 South America Inhalation CDMO Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Inhalation CDMO Market Size Growth Rate (2020-2031)
2 Inhalation CDMO Market by Type

2.1 Type Introduction
2.1.1 Soft Mist Inhalers (SMIs)
2.1.2 Dry Powder Inhalers (DPIs)
2.1.3 Metered Dose Inhalers (MDIs)
2.1.4 Others
2.2 Global Inhalation CDMO Market Size by Type
2.2.1 Global Inhalation CDMO Market Size Overview by Type (2020-2031)
2.2.2 Global Inhalation CDMO Historic Market Size Review by Type (2020-2025)
2.2.3 Global Inhalation CDMO Market Size Forecasted by Type (2026-2031)
2.3 Global Inhalation CDMO Market Size by Regions
2.3.1 North America Inhalation CDMO Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Inhalation CDMO Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Inhalation CDMO Market Size Breakdown by Type (2020-2025)
2.3.4 South America Inhalation CDMO Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Inhalation CDMO Market Size Breakdown by Type (2020-2025)
3 Inhalation CDMO Market by Application

3.1 Type Introduction
3.1.1 Commercial
3.1.2 Academic Research
3.1.3 Others
3.2 Global Inhalation CDMO Market Size by Application
3.2.1 Global Inhalation CDMO Market Size Overview by Application (2020-2031)
3.2.2 Global Inhalation CDMO Historic Market Size Review by Application (2020-2025)
3.2.3 Global Inhalation CDMO Market Size Forecasted by Application (2026-2031)
3.3 Global Inhalation CDMO Market Size by Regions
3.3.1 North America Inhalation CDMO Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Inhalation CDMO Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Inhalation CDMO Market Size Breakdown by Application (2020-2025)
3.3.4 South America Inhalation CDMO Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Inhalation CDMO Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics

4.1 Inhalation CDMO Industry Trends
4.2 Inhalation CDMO Industry Drivers
4.3 Inhalation CDMO Industry Opportunities and Challenges
4.4 Inhalation CDMO Industry Restraints
5 Competitive Insights by Company

5.1 Global Top Players by Inhalation CDMO Revenue (2020-2025)
5.2 Global Inhalation CDMO Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Inhalation CDMO Key Company Headquarters & Area Served
5.4 Global Inhalation CDMO Company, Product Type & Application
5.5 Global Inhalation CDMO Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Inhalation CDMO Market CR5 and HHI
5.6.2 Global Top 5 and 10 Inhalation CDMO Players Market Share by Revenue in 2024
5.6.3 2024 Inhalation CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles

6.1 Aptar Pharma
6.1.1 Aptar Pharma Comapny Information
6.1.2 Aptar Pharma Business Overview
6.1.3 Aptar Pharma Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Aptar Pharma Inhalation CDMO Product Portfolio
6.1.5 Aptar Pharma Recent Developments
6.2 Bend Bioscience
6.2.1 Bend Bioscience Comapny Information
6.2.2 Bend Bioscience Business Overview
6.2.3 Bend Bioscience Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Bend Bioscience Inhalation CDMO Product Portfolio
6.2.5 Bend Bioscience Recent Developments
6.3 Bespak
6.3.1 Bespak Comapny Information
6.3.2 Bespak Business Overview
6.3.3 Bespak Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Bespak Inhalation CDMO Product Portfolio
6.3.5 Bespak Recent Developments
6.4 Catalent
6.4.1 Catalent Comapny Information
6.4.2 Catalent Business Overview
6.4.3 Catalent Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Catalent Inhalation CDMO Product Portfolio
6.4.5 Catalent Recent Developments
6.5 CritiTech
6.5.1 CritiTech Comapny Information
6.5.2 CritiTech Business Overview
6.5.3 CritiTech Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 CritiTech Inhalation CDMO Product Portfolio
6.5.5 CritiTech Recent Developments
6.6 Enteris Biopharma
6.6.1 Enteris Biopharma Comapny Information
6.6.2 Enteris Biopharma Business Overview
6.6.3 Enteris Biopharma Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Enteris Biopharma Inhalation CDMO Product Portfolio
6.6.5 Enteris Biopharma Recent Developments
6.7 Experic
6.7.1 Experic Comapny Information
6.7.2 Experic Business Overview
6.7.3 Experic Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Experic Inhalation CDMO Product Portfolio
6.7.5 Experic Recent Developments
6.8 HCmed
6.8.1 HCmed Comapny Information
6.8.2 HCmed Business Overview
6.8.3 HCmed Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 HCmed Inhalation CDMO Product Portfolio
6.8.5 HCmed Recent Developments
6.9 Hovione
6.9.1 Hovione Comapny Information
6.9.2 Hovione Business Overview
6.9.3 Hovione Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Hovione Inhalation CDMO Product Portfolio
6.9.5 Hovione Recent Developments
6.10 Iconovo
6.10.1 Iconovo Comapny Information
6.10.2 Iconovo Business Overview
6.10.3 Iconovo Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Iconovo Inhalation CDMO Product Portfolio
6.10.5 Iconovo Recent Developments
6.11 Kindeva
6.11.1 Kindeva Comapny Information
6.11.2 Kindeva Business Overview
6.11.3 Kindeva Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 Kindeva Inhalation CDMO Product Portfolio
6.11.5 Kindeva Recent Developments
6.12 Lonza
6.12.1 Lonza Comapny Information
6.12.2 Lonza Business Overview
6.12.3 Lonza Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Lonza Inhalation CDMO Product Portfolio
6.12.5 Lonza Recent Developments
6.13 Particle Sciences
6.13.1 Particle Sciences Comapny Information
6.13.2 Particle Sciences Business Overview
6.13.3 Particle Sciences Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.13.4 Particle Sciences Inhalation CDMO Product Portfolio
6.13.5 Particle Sciences Recent Developments
6.14 Proveris
6.14.1 Proveris Comapny Information
6.14.2 Proveris Business Overview
6.14.3 Proveris Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.14.4 Proveris Inhalation CDMO Product Portfolio
6.14.5 Proveris Recent Developments
6.15 Recipharm
6.15.1 Recipharm Comapny Information
6.15.2 Recipharm Business Overview
6.15.3 Recipharm Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.15.4 Recipharm Inhalation CDMO Product Portfolio
6.15.5 Recipharm Recent Developments
6.16 Renejix
6.16.1 Renejix Comapny Information
6.16.2 Renejix Business Overview
6.16.3 Renejix Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.16.4 Renejix Inhalation CDMO Product Portfolio
6.16.5 Renejix Recent Developments
6.17 Ritedose
6.17.1 Ritedose Comapny Information
6.17.2 Ritedose Business Overview
6.17.3 Ritedose Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.17.4 Ritedose Inhalation CDMO Product Portfolio
6.17.5 Ritedose Recent Developments
6.18 Vectura
6.18.1 Vectura Comapny Information
6.18.2 Vectura Business Overview
6.18.3 Vectura Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.18.4 Vectura Inhalation CDMO Product Portfolio
6.18.5 Vectura Recent Developments
6.19 Sanner
6.19.1 Sanner Comapny Information
6.19.2 Sanner Business Overview
6.19.3 Sanner Inhalation CDMO Revenue, Global Share and Gross Margin (2020-2025)
6.19.4 Sanner Inhalation CDMO Product Portfolio
6.19.5 Sanner Recent Developments
7 North America

7.1 North America Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Inhalation CDMO Market Size by Country (2020-2025)
7.3 North America Inhalation CDMO Market Size Forecast by Country (2026-2031)
8 Europe

8.1 Europe Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Inhalation CDMO Market Size by Country (2020-2025)
8.3 Europe Inhalation CDMO Market Size Forecast by Country (2026-2031)
9 Asia-Pacific

9.1 Asia-Pacific Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Inhalation CDMO Market Size by Country (2020-2025)
9.3 Asia-Pacific Inhalation CDMO Market Size Forecast by Country (2026-2031)
10 South America

10.1 South America Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Inhalation CDMO Market Size by Country (2020-2025)
10.3 South America Inhalation CDMO Market Size Forecast by Country (2026-2031)
11 Middle East & Africa

11.1 Middle East & Africa Inhalation CDMO Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Inhalation CDMO Market Size by Country (2020-2025)
11.3 Middle East & Africa Inhalation CDMO Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix

13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings